Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 2
2006 2
2007 1
2008 11
2009 5
2010 6
2011 6
2012 4
2013 2
2014 3
2015 1
2016 2
2017 4
2018 4
2019 4
2020 2
2021 1
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
PBX3 in Cancer.
Morgan R, Pandha HS. Morgan R, et al. Among authors: pandha hs. Cancers (Basel). 2020 Feb 13;12(2):431. doi: 10.3390/cancers12020431. Cancers (Basel). 2020. PMID: 32069812 Free PMC article. Review.
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy.
Ravaud A, Motzer RJ, Pandha HS, George DJ, Pantuck AJ, Patel A, Chang YH, Escudier B, Donskov F, Magheli A, Carteni G, Laguerre B, Tomczak P, Breza J, Gerletti P, Lechuga M, Lin X, Martini JF, Ramaswamy K, Casey M, Staehler M, Patard JJ; S-TRAC Investigators. Ravaud A, et al. Among authors: pandha hs. N Engl J Med. 2016 Dec 8;375(23):2246-2254. doi: 10.1056/NEJMoa1611406. Epub 2016 Oct 9. N Engl J Med. 2016. PMID: 27718781 Free article. Clinical Trial.
Targeting HOX/PBX dimers in cancer.
Morgan R, El-Tanani M, Hunter KD, Harrington KJ, Pandha HS. Morgan R, et al. Among authors: pandha hs. Oncotarget. 2017 May 9;8(19):32322-32331. doi: 10.18632/oncotarget.15971. Oncotarget. 2017. PMID: 28423659 Free PMC article. Review.
Kinase Regulation of HOX Transcription Factors.
Primon M, Hunter KD, Pandha HS, Morgan R. Primon M, et al. Among authors: pandha hs. Cancers (Basel). 2019 Apr 10;11(4):508. doi: 10.3390/cancers11040508. Cancers (Basel). 2019. PMID: 30974835 Free PMC article. Review.
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors.
Rudin CM, Pandha HS, Zibelman M, Akerley WL, Harrington KJ, Day D, Hill AG, O'Day SJ, Clay TD, Wright GM, Jennens RR, Gerber DE, Rosenberg JE, Ralph C, Campbell DC, Curti BD, Merchan JR, Ren Y, Schmidt EV, Guttman L, Gupta S. Rudin CM, et al. Among authors: pandha hs. J Immunother Cancer. 2023 Jan;11(1):e005007. doi: 10.1136/jitc-2022-005007. J Immunother Cancer. 2023. PMID: 36669791 Free PMC article. Clinical Trial.
HOX genes in pancreatic development and cancer.
Gray S, Pandha HS, Michael A, Middleton G, Morgan R. Gray S, et al. Among authors: pandha hs. JOP. 2011 May 6;12(3):216-9. JOP. 2011. PMID: 21546695 Free article.
Oncolytic viruses: a novel form of immunotherapy.
Prestwich RJ, Harrington KJ, Pandha HS, Vile RG, Melcher AA, Errington F. Prestwich RJ, et al. Among authors: pandha hs. Expert Rev Anticancer Ther. 2008 Oct;8(10):1581-8. doi: 10.1586/14737140.8.10.1581. Expert Rev Anticancer Ther. 2008. PMID: 18925850 Free PMC article. Review.
62 results